Literature DB >> 24234918

Effect of ingested lipids on drug dissolution and release with concurrent digestion: a modeling approach.

Fulden Buyukozturk, Selena Di Maio, David E Budil, Rebecca L Carrier.   

Abstract

PURPOSE: To mechanistically study and model the effect of lipids, either from food or self-emulsifying drug delivery systems (SEDDS), on drug transport in the intestinal lumen.
METHODS: Simultaneous lipid digestion, dissolution/release, and drug partitioning were experimentally studied and modeled for two dosing scenarios: solid drug with a food-associated lipid (soybean oil) and drug solubilized in amodel SEDDS (soybean oil and Tween 80 at 1:1 ratio). Rate constants for digestion, permeability of emulsion droplets, and partition coefficients in micellar and oil phases were measured, and used to numerically solve the developed model.
RESULTS: Strong influence of lipid digestion on drug release from SEDDS and solid drug dissolution into food-associated lipid emulsion was observed and predicted by the developed model. Ninety minutes after introduction of SEDDS, there was 9% and 70% drug release in the absence and presence of digestion, respectively. However, overall drug dissolution in the presence of food-associated lipids occurred over a longer period than without digestion.
CONCLUSION: A systems-based mechanistic model incorporating simultaneous dynamic processes occurring upon dosing of drug with lipids enabled prediction of aqueous drug concentration profile. This model, once incorporated with a pharmacokinetic model considering processes of drug absorption and drug lymphatic transport in the presence of lipids, could be highly useful for quantitative prediction of impact of lipids on bioavailability of drugs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24234918      PMCID: PMC4281523          DOI: 10.1007/s11095-013-1238-6

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  35 in total

Review 1.  Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract.

Authors:  D Hörter; J B Dressman
Journal:  Adv Drug Deliv Rev       Date:  2001-03-01       Impact factor: 15.470

2.  Toward the establishment of standardized in vitro tests for lipid-based formulations, part 1: method parameterization and comparison of in vitro digestion profiles across a range of representative formulations.

Authors:  Hywel D Williams; Philip Sassene; Karen Kleberg; Jean-Claude Bakala-N'Goma; Marilyn Calderone; Vincent Jannin; Annabel Igonin; Anette Partheil; Delphine Marchaud; Eduardo Jule; Jan Vertommen; Mario Maio; Ross Blundell; Hassan Benameur; Frédéric Carrière; Anette Müllertz; Christopher J H Porter; Colin W Pouton
Journal:  J Pharm Sci       Date:  2012-05-29       Impact factor: 3.534

3.  Mechanistic study of the influence of micelle solubilization and hydrodynamic factors on the dissolution rate of solid drugs.

Authors:  P Singh; S J Desai; D R Flanagan; A P Simonelli; W I Higuchi
Journal:  J Pharm Sci       Date:  1968-06       Impact factor: 3.534

4.  Characterisation and quantification of medium chain and long chain triglycerides and their in vitro digestion products, by HPTLC coupled with in situ densitometric analysis.

Authors:  L Sek; C J Porter; W N Charman
Journal:  J Pharm Biomed Anal       Date:  2001-06       Impact factor: 3.935

Review 5.  In vitro assessment of oral lipid based formulations.

Authors:  C J Porter; W N Charman
Journal:  Adv Drug Deliv Rev       Date:  2001-10-01       Impact factor: 15.470

6.  The specific activities of human digestive lipases measured from the in vivo and in vitro lipolysis of test meals.

Authors:  F Carrière; C Renou; V Lopez; J De Caro; F Ferrato; H Lengsfeld; A De Caro; R Laugier; R Verger
Journal:  Gastroenterology       Date:  2000-10       Impact factor: 22.682

7.  Lipid digestion as a trigger for supersaturation: evaluation of the impact of supersaturation stabilization on the in vitro and in vivo performance of self-emulsifying drug delivery systems.

Authors:  Mette U Anby; Hywel D Williams; Michelle McIntosh; Hassan Benameur; Glenn A Edwards; Colin W Pouton; Christopher J H Porter
Journal:  Mol Pharm       Date:  2012-06-15       Impact factor: 4.939

8.  Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products.

Authors:  Leab Sek; Christopher J H Porter; Ann Marie Kaukonen; William N Charman
Journal:  J Pharm Pharmacol       Date:  2002-01       Impact factor: 3.765

9.  Introduction to spin label electron paramagnetic resonance spectroscopy of proteins.

Authors:  Michelle Melanson; Abha Sood; Fanni Török; Marianna Török
Journal:  Biochem Mol Biol Educ       Date:  2012-12-27       Impact factor: 1.160

10.  Drug solubilization behavior during in vitro digestion of suspension formulations of poorly water-soluble drugs in triglyceride lipids.

Authors:  Ann Marie Kaukonen; Ben J Boyd; William N Charman; Christopher J H Porter
Journal:  Pharm Res       Date:  2004-02       Impact factor: 4.200

View more
  4 in total

1.  Food-associated stimuli enhance barrier properties of gastrointestinal mucus.

Authors:  Hasan M Yildiz; Lauren Speciner; Cafer Ozdemir; David E Cohen; Rebecca L Carrier
Journal:  Biomaterials       Date:  2015-03-27       Impact factor: 12.479

2.  Characterization of colloidal structures during intestinal lipolysis using small-angle neutron scattering.

Authors:  Oljora Rezhdo; Selena Di Maio; Peisi Le; Kenneth C Littrell; Rebecca L Carrier; Sow-Hsin Chen
Journal:  J Colloid Interface Sci       Date:  2017-03-30       Impact factor: 8.128

Review 3.  Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement.

Authors:  Oljora Rezhdo; Lauren Speciner; Rebecca Carrier
Journal:  J Control Release       Date:  2016-08-09       Impact factor: 9.776

4.  Size selectivity of intestinal mucus to diffusing particulates is dependent on surface chemistry and exposure to lipids.

Authors:  Hasan M Yildiz; Craig A McKelvey; Patrick J Marsac; Rebecca L Carrier
Journal:  J Drug Target       Date:  2015       Impact factor: 5.121

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.